390 related articles for article (PubMed ID: 24081864)
1. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery.
Coca SG; Garg AX; Swaminathan M; Garwood S; Hong K; Thiessen-Philbrook H; Passik C; Koyner JL; Parikh CR;
Nephrol Dial Transplant; 2013 Nov; 28(11):2787-99. PubMed ID: 24081864
[TBL] [Abstract][Full Text] [Related]
2. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
3. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
[TBL] [Abstract][Full Text] [Related]
4. Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
Bidulka P; Fu EL; Leyrat C; Kalogirou F; McAllister KSL; Kingdon EJ; Mansfield KE; Iwagami M; Smeeth L; Clase CM; Bhaskaran K; van Diepen M; Carrero JJ; Nitsch D; Tomlinson LA
BMC Med; 2020 Jul; 18(1):195. PubMed ID: 32723383
[TBL] [Abstract][Full Text] [Related]
5. Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis.
Shah M; Jain AK; Brunelli SM; Coca SG; Devereaux PJ; James MT; Luo J; Molnar AO; Mrkobrada M; Pannu N; Parikh CR; Paterson M; Shariff S; Wald R; Walsh M; Whitlock R; Wijeysundera DN; Garg AX
BMC Nephrol; 2014 Apr; 15():53. PubMed ID: 24694072
[TBL] [Abstract][Full Text] [Related]
6. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.
Brar S; Ye F; James MT; Hemmelgarn B; Klarenbach S; Pannu N;
JAMA Intern Med; 2018 Dec; 178(12):1681-1690. PubMed ID: 30422153
[TBL] [Abstract][Full Text] [Related]
7. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery.
Arora P; Rajagopalam S; Ranjan R; Kolli H; Singh M; Venuto R; Lohr J
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1266-73. PubMed ID: 18667735
[TBL] [Abstract][Full Text] [Related]
8. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
[TBL] [Abstract][Full Text] [Related]
9. [Effect of early postoperative use of ACEI/ARB or diuretics on the incidence of acute kidney injury after cardiac surgery in elderly patients].
Hu PH; Chen YH; Liang XL; Li RZ; Li ZL; Jiang F; Shi W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul; 25(7):394-8. PubMed ID: 23834935
[TBL] [Abstract][Full Text] [Related]
10. Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France.
Oussalah A; Gleye S; Clerc Urmes I; Laugel E; Callet J; Barbé F; Orlowski S; Malaplate C; Aimone-Gastin I; Caillierez BM; Merten M; Jeannesson E; Kormann R; Olivier JL; Rodriguez-Guéant RM; Namour F; Bevilacqua S; Losser MR; Levy B; Kimmoun A; Gibot S; Thilly N; Frimat L; Schvoerer E; Guéant JL
Clin Infect Dis; 2020 Dec; 71(9):2447-2456. PubMed ID: 32623470
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study.
Roberts DJ; Smith SA; Tan Z; Dixon E; Datta I; Devrome A; Hemmelgarn BR; Tonelli M; Pannu N; James MT
J Surg Res; 2021 Jul; 263():34-43. PubMed ID: 33631376
[TBL] [Abstract][Full Text] [Related]
12. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
[TBL] [Abstract][Full Text] [Related]
13. Renal Safety and Renin-Angiotensin-Aldosterone System Inhibitors in Patients With Contrast Media Exposure: A Multicenter Randomized Controlled Study.
Lin Y; Dong S; Liu Y; Wang Y; Sun X; Yuan J; Yu D; Liu H
J Cardiovasc Pharmacol; 2022 Nov; 80(5):718-724. PubMed ID: 35881908
[TBL] [Abstract][Full Text] [Related]
14. Renin-Angiotensin-Aldosterone System Blockade after AKI with or without Recovery among US Veterans with Diabetic Kidney Disease.
Murphy DP; Wolfson J; Reule S; Johansen KL; Ishani A; Drawz PE
J Am Soc Nephrol; 2023 Oct; 34(10):1721-1732. PubMed ID: 37545022
[TBL] [Abstract][Full Text] [Related]
15. Study of Acute Kidney Injury on 309 Hypertensive Inpatients with ACEI/ARB - Diuretic Treatment.
Chen Q; Zhu S; Liao J; He W
J Natl Med Assoc; 2018 Jun; 110(3):287-296. PubMed ID: 29778133
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with biochemically detected and hospitalised acute kidney injury in patients prescribed renin angiotensin system inhibitors.
Mark PB; Papworth R; Ramparsad N; Tomlinson LA; Sawhney S; Black C; McConnachie A; McCowan C
Br J Clin Pharmacol; 2020 Jan; 86(1):121-131. PubMed ID: 31663151
[TBL] [Abstract][Full Text] [Related]
17. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.
Gayat E; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Jaber S; Chousterman BG; Lu Q; Laterre PF; Monnet X; Darmon M; Leone M; Guidet B; Sonneville R; Lefrant JY; Fournier MC; Resche-Rigon M; Mebazaa A; Legrand M;
Intensive Care Med; 2018 May; 44(5):598-605. PubMed ID: 29766216
[TBL] [Abstract][Full Text] [Related]
18. Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
Lam KW; Chow KW; Vo J; Hou W; Li H; Richman PS; Mallipattu SK; Skopicki HA; Singer AJ; Duong TQ
J Infect Dis; 2020 Sep; 222(8):1256-1264. PubMed ID: 32702098
[TBL] [Abstract][Full Text] [Related]
19. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis.
Whitlock R; Leon SJ; Manacsa H; Askin N; Rigatto C; Fatoba ST; Farag YMK; Tangri N
Nephrol Dial Transplant; 2023 Oct; 38(11):2503-2516. PubMed ID: 37309038
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis.
Chen JY; Tsai IJ; Pan HC; Liao HW; Neyra JA; Wu VC; Chueh JS
Front Pharmacol; 2021; 12():665250. PubMed ID: 34354583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
